ELA vs. ARWR

Last updated Aug 6, 2026

ELA (Envela Corporation) and ARWR (Arrowhead Pharmaceuticals, Inc.) are both stocks. ELA operates in Luxury Goods (Consumer Cyclical), while ARWR operates in Biotechnology (Healthcare). Over the past 10 years, ELA returned 37.01%/yr vs 30.67%/yr for ARWR. Their 0.06 correlation means their historical movements had little consistent relationship.

Performance

ELA vs. ARWR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Envela Corporation (ELA) and Arrowhead Pharmaceuticals, Inc. (ARWR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ELA achieves a 58.52% return, which is significantly higher than ARWR's 30.91% return. Over the past 10 years, ELA has outperformed ARWR with an annualized return of 37.01%, while ARWR has yielded a comparatively lower 30.67% annualized return.

ELA

• 1D: -3.28%
• 1M: -15.63%
• 6M: 64.67%
• YTD: 58.52%
• 1Y: 277.40%
• 3Y*: 57.58%
• 5Y*: 35.46%
• 10Y*: 37.01%
• ALL TIME*: 5.72%

ARWR

• 1D: -2.99%
• 1M: 0.42%
• 6M: 27.70%
• YTD: 30.91%
• 1Y: 427.69%
• 3Y*: 40.03%
• 5Y*: 6.05%
• 10Y*: 30.67%
• ALL TIME*: -0.61%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
ARWR Arrowhead Pharmaceuticals, Inc.	$158.07M	$184.04M	$176.79M
ELA Envela Corporation	$2.52M	$2.86M	$3.07M

ELA vs. ARWR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ELA Envela Corporation	58.52%	86.35%	47.74%	-7.60%	29.24%	-21.73%	285.19%	193.54%	-50.55%	-25.00%
ARWR Arrowhead Pharmaceuticals, Inc.	30.91%	253.14%	-38.56%	-24.56%	-38.82%	-13.59%	20.97%	410.71%	237.50%	137.42%

Correlation

The correlation between ELA and ARWR is 0.11, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.11
Correlation (3Y) Balances recent behavior with more history.	0.20
Correlation (5Y) Shows whether the relationship held over a longer period.	0.20
Correlation (10Y) Provides a long-term view across more market conditions.	0.12
Correlation (All Time) Calculated using the full available price history since Jan 6, 1997	0.06

The correlation between ELA and ARWR shifts across timeframes, from 0.06 (all time) to 0.20 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ELA : $550.69M ARWR : $12.24B
EPS ELA : $0.86 ARWR : -$2.28
PS Ratio ELA : 1.88 ARWR : 18.25
PB Ratio ELA : 6.88 ARWR : 26.74
Total Revenue (TTM) ELA : $293.04M ARWR : $669.50M
Gross Profit (TTM) ELA : $63.57M ARWR : $594.24M
EBITDA (TTM) ELA : $27.22M ARWR : -$156.08M

Return for Risk

ELA vs. ARWR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

ELA

ELA Risk / Return Rank: 98
ELA Sharpe Ratio Rank: 99
ELA Sortino Ratio Rank: 97
ELA Omega Ratio Rank: 96
ELA Calmar Ratio Rank: 99
ELA Martin Ratio Rank: 98

ARWR

ARWR Risk / Return Rank: 99
ARWR Sharpe Ratio Rank: 100
ARWR Sortino Ratio Rank: 99
ARWR Omega Ratio Rank: 98
ARWR Calmar Ratio Rank: 100
ARWR Martin Ratio Rank: 99

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

ELA vs. ARWR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Envela Corporation (ELA) and Arrowhead Pharmaceuticals, Inc. (ARWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ELA	ARWR	Difference
Sharpe ratio: Return per unit of total volatility	3.91	6.56	-2.65
Sortino ratio: Return per unit of downside risk	4.18	5.66	-1.48
Omega ratio: Gain probability vs. loss probability	1.53	1.69	-0.16
Calmar ratio: Return relative to maximum drawdown	9.80	17.50	-7.69
Martin ratio: Return relative to average drawdown	27.81	50.68	-22.87

ELA vs. ARWR - Sharpe Ratio Comparison

The current ELA Sharpe Ratio is 3.91, which is lower than the ARWR Sharpe Ratio of 6.56. The chart below compares the historical Sharpe Ratios of ELA and ARWR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ELA vs. ARWR - Drawdown Comparison

The maximum ELA drawdown since its inception was -97.32%, roughly equal to the maximum ARWR drawdown of -99.24%. Use the drawdown chart below to compare losses from any high point for ELA and ARWR.

Drawdown Indicators

	ELA	ARWR	Difference
Max Drawdown Largest peak-to-trough decline	-97.32%	-99.24%	+1.92%
Max Drawdown (1Y) Largest decline over 1 year	-28.50%	-24.64%	-3.86%
Max Drawdown (3Y) Largest decline over 3 years	-45.05%	-74.70%	+29.65%
Max Drawdown (5Y) Largest decline over 5 years	-61.53%	-87.89%	+26.36%
Max Drawdown (10Y) Largest decline over 10 years	-78.03%	-88.96%	+10.93%
Current Drawdown Current decline from peak	-26.56%	-46.52%	+19.96%
Average Drawdown Average peak-to-trough decline	-57.45%	-81.06%	+23.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.03%	8.49%	+1.54%

Volatility

ELA vs. ARWR - Volatility Comparison

The current volatility for Envela Corporation (ELA) is 9.84%, while Arrowhead Pharmaceuticals, Inc. (ARWR) has a volatility of 23.14%. This indicates that ELA experiences smaller price fluctuations and is considered to be less risky than ARWR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ELA	ARWR	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.84%	23.14%	-13.30%
Volatility (6M) Calculated over the trailing 6-month period	50.40%	39.04%	+11.36%
Volatility (1Y) Calculated over the trailing 1-year period	71.52%	65.78%	+5.74%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	53.78%	64.67%	-10.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	65.16%	74.41%	-9.25%

Dividends

ELA vs. ARWR - Dividend Comparison

Neither ELA nor ARWR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ELA and ARWR in my portfolio?

ELA and ARWR have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ELA or ARWR?

ARWR has higher volatility (23.14%) compared to ELA (9.84%). In terms of maximum drawdown, ELA dropped -97.32% vs ARWR's -99.24%.

Which has better risk-adjusted returns?

ARWR currently has the higher Sharpe Ratio (6.56 vs 3.91), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.